Qiming Venture Partners

Portfolio Companies 2026 for Qiming Venture Partners: investors, rounds, and co-investor patterns from StartupFundraising.com research, updated for 2026.

Qiming Venture Partners accounts for 92 tracked companies with verified cap-table data, 92 of which disclose round sizes totalling $16B. The median disclosed raise is $110M, and the largest is Dingdong Maicai at $1.3B, ahead of Galaxy Bot ($1.1B) and Meitu ($989M).

The names that recur most often on these portfolio cap tables are Qiming Venture Partners (95 companies), Lilly Asia Ventures (9 companies), Legend Capital (8 companies), TF Capital (8 companies), OrbiMed (8 companies), IDG Capital (7 companies). By latest disclosed round, the market skews Series B (27), Series C (16), Series A (15), Series D (9).

Best funded Qiming Venture Partners companies

  1. Dingdong Maicai — $1.3B (latest: Series D)
  2. Galaxy Bot — $1.1B (latest: Growth)
  3. Meitu — $989M (latest: Series B)
  4. StepFun — $719M (latest: Series B+)
  5. Axera — $672M (latest: Series C)
  6. Akulaku — $536M (latest: Growth)
  7. Antengene Corporation — $488M (latest: IPO)
  8. Mafengwo — $383M (latest: Series E)
  9. Qiniu — $381M (latest: IPO)
  10. Unisound — $340M (latest: IPO)
  11. Berry Oncology — $309M (latest: Series B)
  12. AliExpress Russia — $290M (latest: Series B)
  13. ZEGO Technology — $282M (latest: Series C)
  14. Shukun Technology — $274M (latest: Other Equity)
  15. Belief Biomed — $271M (latest: Series C)

Qiming Venture Partners — related firms and companies (56)

Qiming Venture Partners profile · All research reports